Fox Chase Cancer Center News

PHILADELPHIA (September 11, 2019) – Anne Jadwin, MSN, RN, AOCN, NE-BC, Vice President of Nursing Services and Chief Nursing Officer, was honored with the 2019 Distinguished Alumni Award from Gwynedd Mercy University. The award recognizes the achievements of outstanding alumni whose “personal lives, professional achievements, and community service exemplify the objectives of their alma mater.”

PHILADELPHIA (September 10, 2019) – Marcin Chwistek, MD, FAAHPM, director of the Pain and Palliative Care Program, has been appointed Editor-in-Chief of AAHPM Quarterly.

PHILADELPHIA (September 9, 2019) – Andrew J. Andrews, PhD, has been awarded a $33,348 grant from the National Cancer Institute for research attempting to determine the fundamental processes by which cancer cells can sense deficiencies in the production of essential metabolic components and adapt to overcome this and survive.

PHILADELPHIA (September 4, 2019) – Eric D. Tetzlaff, MHS, PA-C, a physician assistant at Fox Chase Cancer Center, has received a $15,000 three-year grant from The Association of Physician Assistants in Oncology to explore the role and impact of burnout among physician assistants working in oncology.

PHILADELPHIA (September 4, 2019) – Research by Carolyn Y. Fang, PhD, and colleagues at Fox Chase Cancer Center showed that among Chinese immigrant women in and around Philadelphia, the relationship between markers of inflammation and risk for breast cancer varied according to their neighborhoods.

PHILADELPHIA (September 3, 2019) — Fox Chase Cancer Center will hold its 20th annual Paws for the Cause, hosted by the Board of Associates, on Sunday, October 6, 2019, from 9:00 am to 12 pm.

PHILADELPHIA (September 3, 2019) – September is National Prostate Cancer Awareness month. The American Cancer Society (ACS) reports that prostate cancer is the most common cancer in American men, other skin cancer.

PHILADELPHIA — (August 28, 2019) Dietmar J. Kappes, PhD, has received a five-year, $626,072 grant from The National Institutes of Health to investigate the role of the immune gene ThPOK in breast cancer.